Genentech Misses Enbrel Deadline; Amgen Contract Facility Not Ready
Executive Summary
Genentech will not be reimbursed by Amgen for certain Enbrel manufacturing investments because Genentech's contract production line will not be ready on time, the company disclosed in its 2003 110-K filing